Lessons for Canada on Prior Authorization Reform: An American Experience

Since 2020, the conversation around improving the prior authorization process and experience has been gaining traction in Canada. However, there has been much more than discussion in the U.S. Learn what Canadian stakeholders can take away from American developments.
The First Prior Authorization Resource for Prescribers

Are you a physician, pharmacist, or other prescriber that has patients with a prescription for specialty medications? If you are, it’s likely that your patients have a prescription for a therapy or medication that requires prior authorization, and they probably have questions about it.
The First Prior Authorization Resource for Patient Support Programs

Do you represent a patient support/assistance program (PSP/PAP)? If you do, it’s likely that the patients you help have a prescription for a therapy or medication that requires prior authorization, and they probably have questions about it.
June is Migraine Awareness Month – How ePA can help patients and payers manage migraine

Advancements in medical research have yielded innovative medications in recent years and can significantly improve the lives of those living with migraine.
Look Who Has Joined the Simplify Prior Authorization Initiative

The Simplify Prior Authorization (SPA) initiative is pleased to announce that Innomar Strategies has joined the growing list of organizations working together for an improved prior authorization process.
The First Prior Authorization Resource for Insurers and Pharmacy Benefit Managers

Do you represent a private payer, such as an insurer or pharmacy benefit manager (PBM)? If so, you may be familiar with your organization’s role in the prior authorization process, a process that can be unique to each insurer, including claims criteria for approval.
The First Prior Authorization Resource for Plan Sponsors or Advisors

Are you a plan sponsor or advisor? Do your plan members have claims for specialty drugs? If so, it’s likely that plan members have questions regarding the prior authorization process, a process common for the reimbursement of specialty drugs
Why it’s Time to Change the Prior Authorization Process

Read our new article in the May edition of the Benefits and Pension Monitor magazine, where we explore the history of prior authorization, specialty drug spend, new technologies and solutions to advance prior authorization.
The First Prior Authorization Resource for Patients

Do you or your clients have specialty drug claims on group benefit plans? If so, you need to read this blog and find out about the new patient information and resources website.
Prior Authorization 2023: New Resources and Solutions

The Simplify Prior Authorization (SPA) initiative recently hosted its first webinar in 2023 for group benefits stakeholders on new prior authorization (PA) resources and solutions. Interest was high, with the largest registration numbers since the initiative began.